Class information for:
Level 2: CD40//BAFF//CD40 LIGAND

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
914 10549 42.5 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
18 119602 JOURNAL OF IMMUNOLOGY//IMMUNOL//DENDRITIC CELLS

Classes in level below (level 1)


ID, lev. below Publications Label for level below
622 3151 MORRIS HEPATOMA 5123//TNF RECEPTORS//ENDOGENOUS TNF ALPHA
2473 2164 CD40//CD40 LIGAND//CD40L
4988 1622 BAFF//APRIL//BLYS
6361 1429 LYMPHOTOXIN//LT BETA R//BTLA
13274 784 TAK1//TRAF4//TRAF5
17012 558 SOLUBLE CD30//SCD30//CD30
21709 351 FN14//TWEAK//STWEAK
22672 317 DCR3//DECOY RECEPTOR 3//TL1A
28191 173 PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CD40 Author keyword 246 42% 4% 452
2 BAFF Author keyword 211 67% 2% 191
3 CD40 LIGAND Author keyword 167 53% 2% 223
4 TWEAK Author keyword 154 73% 1% 117
5 APRIL Author keyword 149 77% 1% 102
6 FN14 Author keyword 141 84% 1% 76
7 CD40L Author keyword 91 44% 1% 155
8 BLYS Author keyword 83 73% 1% 63
9 DCR3 Author keyword 81 87% 0% 40
10 SOLUBLE CD30 Author keyword 81 83% 0% 45

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CD40 246 42% 4% 452 Search CD40 Search CD40
2 BAFF 211 67% 2% 191 Search BAFF Search BAFF
3 CD40 LIGAND 167 53% 2% 223 Search CD40+LIGAND Search CD40+LIGAND
4 TWEAK 154 73% 1% 117 Search TWEAK Search TWEAK
5 APRIL 149 77% 1% 102 Search APRIL Search APRIL
6 FN14 141 84% 1% 76 Search FN14 Search FN14
7 CD40L 91 44% 1% 155 Search CD40L Search CD40L
8 BLYS 83 73% 1% 63 Search BLYS Search BLYS
9 DCR3 81 87% 0% 40 Search DCR3 Search DCR3
10 SOLUBLE CD30 81 83% 0% 45 Search SOLUBLE+CD30 Search SOLUBLE+CD30

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NECROSIS FACTOR FAMILY 725 79% 4% 469
2 B LYMPHOCYTE STIMULATOR 330 71% 3% 265
3 LYMPHOCYTE STIMULATOR 307 80% 2% 191
4 BLYS 278 82% 2% 164
5 WEAK INDUCER 262 86% 1% 134
6 HERPESVIRUS ENTRY MEDIATOR 214 64% 2% 209
7 LYMPHOTOXIN BETA RECEPTOR 195 49% 3% 291
8 BAFF 186 51% 2% 258
9 BAFF R 178 78% 1% 116
10 TNF FAMILY 174 62% 2% 180

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LYMPHOKINE AND CYTOKINE RESEARCH 6 15% 0% 35
2 LYMPHOKINE RESEARCH 4 12% 0% 34
3 JOURNAL OF INFLAMMATION 3 19% 0% 15

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Cracking the BAFF code 2009 273 106 70%
The TNF and TNF receptor superfamilies: Integrating mammalian biology 2001 1868 102 40%
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity 2013 41 141 79%
Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies 2015 3 39 51%
CD40-CD40 ligand 2000 776 128 77%
The BAFF/APRIL system in SLE pathogenesis 2014 16 100 71%
CCR7 and its ligands: balancing immunity and tolerance 2008 370 88 43%
Targeting of TAK1 in inflammatory disorders and cancer 2012 71 90 60%
Molecular mechanism and function of CD40/CD40L engagement in the immune system 2009 227 217 49%
CD40 and CD154 in cell-mediated immunity 1998 1038 102 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 JIANGSU PROV MOL MED BIOTECHNOL 17 28% 0.5% 51
2 MOL TUMOR GENET IMMUNOGENET 7 53% 0.1% 10
3 EXPLORATORY SCI 7 46% 0.1% 11
4 PHARMACEUT PROTE 6 34% 0.1% 14
5 PATHOL TUMOR IMMUNOL 6 50% 0.1% 8
6 TEACHING WARD INTERNAL MED 6 100% 0.0% 4
7 CAMBRIDGE 12 5 39% 0.1% 11
8 TUMOR GENET IMMUNOGENET 5 34% 0.1% 13
9 CHARITE 12 5 63% 0.0% 5
10 CHARITE 14 4 75% 0.0% 3

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000018882 I KAPPA B//C REL//IKK
2 0.0000013053 FOXP3//CTLA 4//REGULATORY T CELLS
3 0.0000011875 INTERLEUKIN 10//IL 1RN//INTERLEUKIN 1 BETA GENE
4 0.0000011052 COLLAGEN INDUCED ARTHRITIS//SECT MED INFLAMMAT//INTERLEUKIN 1 RECEPTOR ANTAGONIST
5 0.0000009359 SOMATIC HYPERMUTATION//VDJ RECOMBINATION//CLASS SWITCH RECOMBINATION
6 0.0000009164 JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180
7 0.0000009141 SPLUNC1//ENDOTOXIN REMOVAL//POLYMYXIN B IMMOBILIZED FIBER
8 0.0000008743 FOLLICULAR DENDRITIC CELLS//CLUSTER OF DIFFERENTIATION CD ANTIGENS//ILEAL PEYERS PATCH
9 0.0000008447 SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS
10 0.0000008296 ORAL TOLERANCE//DC SIGN//DENDRITIC CELLS